脳卒中の診断および治療の世界市場2017-2026

◆英語タイトル:Stroke Diagnostics and Therapeutics - Global Market Outlook (2017-2026)
◆商品コード:SMRC809034
◆発行会社(リサーチ会社):Stratistics MRC
◆発行日:2018年8月20日
◆ページ数:188
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥468,950見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥593,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Stratistics MRC社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、脳卒中の診断および治療の世界市場について調査・分析し、市場概要、市場環境、脳卒中の診断および治療市場規模、タイプ別(診断、治療)分析、用途別(出血性脳卒中、虚血性脳卒中分析、用途別(出血性脳卒中、虚血性脳卒中)分析、市場動向、競争環境、主要地域別市場規模(アメリカ、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・ エグゼクティブサマリー
・ 序文
・ 脳卒中の診断および治療の世界市場:市場動向分析
・ 脳卒中の診断および治療の世界市場:競争要因分析
・ 脳卒中の診断および治療の世界市場:タイプ別(診断、治療)
・ 脳卒中の診断および治療の世界市場:用途別(出血性脳卒中、虚血性脳卒中
・ 脳卒中の診断および治療の世界市場:用途別(出血性脳卒中、虚血性脳卒中)
・ 脳卒中の診断および治療の世界市場:主要地域別分析
・ 脳卒中の診断および治療の北米市場規模(アメリカ市場等)
・ 脳卒中の診断および治療のヨーロッパ市場規模
・ 脳卒中の診断および治療のアジア市場規模(日本市場、中国市場、インド市場等)
・脳卒中の診断および治療の世界市場:主な市場開拓
・ 関連企業分析
【レポートの概要】

According to Stratistics MRC, the Global Stroke Diagnostics and Therapeutics market is accounted for $23,849.39 Million in 2017 and is expected to reach $49,698.68 Million by 2026 growing at a CAGR of 8.5% during the forecast period. Factors such as technological advancement, growing aging population, and people suffering from diabetes are favouring the market. On the other hand, increasing health expenditure, hypertension and also increasing tobacco users are also fuelling the market. However factors such as unfavourable reimbursement scenario and high cost of treatments are hampering the market growth. Stroke is referred to brain attack occurs when there is a holdup in the supply of blood to the brain which leads brain cells to die.

Depending upon Application, Haemorrhagic Stroke is caused on account of the arteries in the brain either leaking blood or bursting open. When it happens, blood collects in the brain tissue. This is toxic for the brain tissue causing the cells in that area to weaken and die. It is one among the cause of death and a leading cause of serious, long-term disability across the world.

By Geography, stroke diagnostics and therapeutics market in Asia is expected to witness the high growth rate in and expected to remain top among other regions in the forecast period due to growing aging population, evolving R&D activities for drug discovery and development, increasing government support in the form of funding and developing healthcare infrastructure in the region. In addition, growing demographics and economies in the developing countries such as India, China, and Japan are expected to lead the growth in the stroke diagnostics and therapeutics market in Asia.

Some of the key players diagnostics and therapeutics market include are Siemens AG, GE Healthcare, Medtronic plc, Bayer AG, Abbott Laboratories, Cordis Corporation, Boston Scientific Corporation, Genentech, Inc., Koninklijke Philips N.V., Stryker Corporation, Merck & Co., Inc, B. Braun Melsungen AG, Teleflex Inc., Cardinal Health, Merck Sharp & Dohme Corp., GlaxoSmithKline plc, Bristol-Myers Squibb., Boehringer Ingelheim, Johnson & Johnson and Daiichi Sankyo.

Types Covered:
• Diagnostics
• Therapeutics

Applications Covered:
• Haemorrhagic Stroke
• Ischemic Stroke

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Stroke Diagnostics and Therapeutics Market, By Type
5.1 Introduction
5.2 Diagnostics
5.2.1 Magnetic Resonance Imaging (MRI)
5.2.2 Computed Tomography Scan (CT scan)
5.2.3 Electrocardiography
5.2.4 Carotid Ultrasound
5.2.5 Cerebral Angiography
5.2.6 Other Diagnostics
5.3 Therapeutics
5.3.1 Tissue Plasminogen Activator
5.3.2 Antiplatelet
5.3.3 Antihypertensive
5.3.4 Anticoagulant

6 Global Stroke Diagnostics and Therapeutics Market, By Application
6.1 Introduction
6.2 Haemorrhagic Stroke
6.3 Ischemic Stroke

7 Global Stroke Diagnostics and Therapeutics Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa

8 Key Developments
8.1 Acquisitions & Mergers
8.2 Agreements, Partnerships, Collaborations and Joint Ventures
8.3 Product Launch & Expansions
8.4 Other Activities

9 Company Profiling
9.1 Siemens AG
9.2 GE Healthcare
9.3 Medtronic plc
9.4 Bayer AG
9.5 Abbott Laboratories
9.6 Cordis Corporation
9.7 Boston Scientific Corporation
9.8 Genentech, Inc.
9.9 Koninklijke Philips N.V.
9.10 Stryker Corporation
9.11 Merck & Co., Inc
9.12 B. Braun Melsungen AG
9.13 Teleflex Inc.
9.14 Cardinal Health
9.15 Merck Sharp & Dohme Corp.
9.16 GlaxoSmithKline plc
9.17 Bristol-Myers Squibb.
9.18 Boehringer Ingelheim
9.19 Johnson & Johnson
9.20 Daiichi Sankyo

List of Tables
Table 1 Global Stroke Diagnostics and Therapeutics Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 3 Global Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 4 Global Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 5 Global Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 6 Global Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 7 Global Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 8 Global Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 9 Global Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 10 Global Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 11 Global Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 12 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 13 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 14 Global Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 15 Global Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 16 Global Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 17 Global Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 18 North America Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 19 North America Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 20 North America Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 21 North America Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 22 North America Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 23 North America Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 24 North America Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 25 North America Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 26 North America Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 27 North America Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 28 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 29 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 30 North America Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 31 North America Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 32 North America Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 33 North America Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 34 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 35 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 36 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 37 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 38 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 39 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 40 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 41 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 42 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 43 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 44 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 45 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 46 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 47 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 48 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 49 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 50 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 51 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 52 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 53 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 54 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 55 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 56 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 57 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 58 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 59 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 60 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 61 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 62 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 63 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 64 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 65 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 66 South America Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 67 South America Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 68 South America Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 69 South America Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 70 South America Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 71 South America Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 72 South America Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 73 South America Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 74 South America Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 75 South America Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 76 South America Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 77 South America Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 78 South America Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 79 South America Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 80 South America Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 81 South America Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
Table 82 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
Table 83 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 84 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
Table 85 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
Table 86 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
Table 87 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
Table 88 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
Table 89 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
Table 90 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 91 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
Table 92 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
Table 93 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
Table 94 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
Table 95 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
Table 96 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
Table 97 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[脳卒中の診断および治療の世界市場2017-2026]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆